Novozymes A/S Statistics
Share Statistics
Novozymes A/S has 466.14M
shares outstanding. The number of shares has increased by 0.33%
in one year.
| Shares Outstanding | 466.14M |
| Shares Change (YoY) | 0.33% |
| Shares Change (QoQ) | 0.33% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 1.5M, so 0% of the outstanding
shares have been sold short.
| Short Interest | 1.5M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 253.08 |
Valuation Ratios
The PE ratio is 589.77 and the forward
PE ratio is null.
Novozymes A/S's PEG ratio is
-6.28.
| PE Ratio | 589.77 |
| Forward PE | n/a |
| PS Ratio | 47.05 |
| Forward PS | n/a |
| PB Ratio | 16.14 |
| P/FCF Ratio | 273.22 |
| PEG Ratio | -6.28 |
Financial Ratio HistoryEnterprise Valuation
Novozymes A/S has an Enterprise Value (EV) of 181.87B.
| EV / Sales | 47.44 |
| EV / EBITDA | 275.98 |
| EV / EBIT | 178.32 |
| EV / FCF | 275.52 |
Financial Position
The company has a current ratio of 1.73,
with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.73 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 2.73 |
| Debt / FCF | 2.72 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 2.74% and Return on Invested Capital is 3.36%.
| Return on Equity | 2.74% |
| Return on Assets | 2.01% |
| Return on Invested Capital | 3.36% |
| Revenue Per Employee | $362,266.11 |
| Profits Per Employee | $28,898.13 |
| Employee Count | 10,582 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.81 |
Taxes
| Income Tax | 111.3M |
| Effective Tax Rate | 26.68% |
Stock Price Statistics
The stock price has increased by 11.86% in the
last 52 weeks. The beta is 0.55, so Novozymes A/S's
price volatility has been higher than the market average.
| Beta | 0.55 |
| 52-Week Price Change | 11.86% |
| 50-Day Moving Average | 60.14 |
| 200-Day Moving Average | 61.03 |
| Relative Strength Index (RSI) | 62.98 |
| Average Volume (20 Days) | 1,260 |
Income Statement
In the last 12 months, Novozymes A/S had revenue of 3.83B
and earned 305.8M
in profits. Earnings per share was 0.67.
| Revenue | 3.83B |
| Gross Profit | 1.81B |
| Operating Income | 659M |
| Net Income | 305.8M |
| EBITDA | 659M |
| EBIT | 659M |
| Earnings Per Share (EPS) | 0.67 |
Full Income StatementBalance Sheet
The company has 280M in cash and 1.8B in
debt, giving a net cash position of -1.52B.
| Cash & Cash Equivalents | 280M |
| Total Debt | 1.8B |
| Net Cash | -1.52B |
| Retained Earnings | 11.03B |
| Total Assets | 15.2B |
| Working Capital | 791.1M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 1.02B
and capital expenditures -359.8M, giving a free cash flow of 660.1M.
| Operating Cash Flow | 1.02B |
| Capital Expenditures | -359.8M |
| Free Cash Flow | 660.1M |
| FCF Per Share | 1.45 |
Full Cash Flow StatementMargins
Gross margin is 47.2%, with operating and profit margins of 17.19% and 7.98%.
| Gross Margin | 47.2% |
| Operating Margin | 17.19% |
| Pretax Margin | 10.88% |
| Profit Margin | 7.98% |
| EBITDA Margin | 17.19% |
| EBIT Margin | 17.19% |
| FCF Margin | 17.22% |
